ILK and breast cancer: Therefore, the Wnt1/ILK-mediated upregulation of nuclear β-catenin shown both in vitro [17] and in vivo (Figure 4) could potentially be responsible for the observed upregulation of FOXA1 expression in the Wnt1/ILK mammary tumors.